Pharmacists Reaching Out in Diabetes: Optimizing Insulin Therapy Through Patient Engagement and Management

,
Pharmacy Times, April 2016 Respiratory Health, Volume 82, Issue 4

This Continuing Education activity is supported by an educational grant from Novo Nordisk.

This activity is supported by an educational grant from Novo Nordisk.

Pharmacists Reaching Out in Diabetes: Optimizing Insulin Therapy Through Patient Engagement and Management

Faculty

Jessica L. Kerr, PharmD, CDE

Associate Professor

Assistant Chair, Department of Pharmacy Practice

Southern Illinois University Edwardsville School of Pharmacy

Edwardsville, Illinois

Editorial Support

Jill Allen, PharmD

Drug Information Consultant

Pin Oak Associates

Salt Lake City, Utah

Educational Objectives

After completing this continuing education program, the participant will be able to:

  • Examine the use of insulin, including pharmacokinetic parameters to reach glycemic control in patients with type 2 diabetes mellitus (T2DM).
  • Identify potential patient barriers and recommended solutions to initiating insulin therapy to optimize A1C goals.
  • Explore the role of new long-acting basal insulins in patients with T2DM and evaluate risk of hypoglycemia associated with each.
  • Analyze the role of the pharmacist in educating patients about proper insulin administration technique and self-monitoring.
  • Illustrate an educational strategy that includes a demonstration of proper administration technique to patients and support them with initiating insulin when appropriate.

Target audience: P

harmacists

Type of activity: Application

Release date: April 12, 2016

Expiration date: April 12, 2017

Estimated time to complete activity: 2.0 hours

Fee: Free

Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-16-054-H01-P. The activity is available for CE credit through March 7, 2018.